Header

UZH-Logo

Maintenance Infos

Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study


Locatelli, Franco; Zugmaier, Gerhard; Mergen, Noemi; Bader, Peter; Jeha, Sima; Schlegel, Paul-Gerhardt; Bourquin, Jean-Pierre; Handgretinger, Rupert; Brethon, Benoit; Rossig, Claudia; Chen-Santel, Christiane (2020). Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study. Blood Cancer Journal, 10(7):77.

Statistics

Citations

Dimensions.ai Metrics
3 citations in Web of Science®
4 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 27 Jan 2021
1 download since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, not_refereed, original work
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Hematology
Health Sciences > Oncology
Language:English
Date:24 July 2020
Deposited On:27 Jan 2021 10:07
Last Modified:01 Feb 2021 16:30
Publisher:Nature Publishing Group
ISSN:2044-5385
OA Status:Gold
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1038/s41408-020-00342-x
PubMed ID:32709851

Download

Gold Open Access

Download PDF  'Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study'.
Preview
Content: Published Version
Filetype: PDF
Size: 397kB
View at publisher
Licence: Creative Commons: Attribution 4.0 International (CC BY 4.0)